http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105560237-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a108c8153d3e907c41bc537b94bc333 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2014-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fe595365a812e19458ed012a299269d |
| publicationDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105560237-A |
| titleOfInvention | Sitafloxacin pharmaceutical composition and preparation method thereof |
| abstract | The present invention discloses a sitafloxacin pharmaceutical composition, which contains 1 part of sitafloxacin, 0.6-1 part of mannitol, 1.2-1.8 parts of microcrystalline cellulose, and 0.2-1 part of cross-linked carboxymethylcellulose sodium. The sitafloxacin pharmaceutical composition of the present invention has characteristics of good stability, effective dissolution increasing and significantly-increased bioavailability, and provides significant advantages for product yield improvement, cost reduction, industrialization achievement, and good clinical application. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113181125-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113181125-A |
| priorityDate | 2014-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.